HEADER SIGNALING PROTEIN,TRANSFERASE/INHIBITOR 18-SEP-23 8U8J TITLE CO-CRYSTAL STRUCTURE OF PHOSPHORYLATED ERK2 IN COMPLEX WITH ERK1/2 TITLE 2 INHIBITOR #16 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAP KINASE 1,MAPK 1,ERT1,EXTRACELLULAR SIGNAL-REGULATED COMPND 5 KINASE 2,ERK-2,MAP KINASE ISOFORM P42,P42-MAPK,MITOGEN-ACTIVATED COMPND 6 PROTEIN KINASE 2,MAP KINASE 2,MAPK 2; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK1, ERK2, PRKM1, PRKM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS PROTEIN KINASE, ATP-COMPETITIVE INHIBITOR, CONFORMATION SELECTION, KEYWDS 2 SIGNALING PROTEIN, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.W.ANDERSON,G.P.VIGERS REVDAT 3 23-OCT-24 8U8J 1 REMARK REVDAT 2 10-APR-24 8U8J 1 JRNL REVDAT 1 27-MAR-24 8U8J 0 JRNL AUTH J.W.ANDERSON,D.VAISAR,D.N.JONES,L.M.PEGRAM,G.P.VIGERS, JRNL AUTH 2 H.CHEN,J.G.MOFFAT,N.G.AHN JRNL TITL CONFORMATION SELECTION BY ATP-COMPETITIVE INHIBITORS AND JRNL TITL 2 ALLOSTERIC COMMUNICATION IN ERK2. JRNL REF ELIFE V. 12 2024 JRNL REFN ESSN 2050-084X JRNL PMID 38537148 JRNL DOI 10.7554/ELIFE.91507 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.56 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 86.5 REMARK 3 NUMBER OF REFLECTIONS : 25560 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1299 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.5600 - 4.3500 1.00 3286 185 0.1673 0.1993 REMARK 3 2 4.3500 - 3.4600 0.99 3141 162 0.1531 0.1779 REMARK 3 3 3.4600 - 3.0300 0.99 3091 163 0.1852 0.2617 REMARK 3 4 3.0300 - 2.7500 0.96 2967 178 0.2028 0.2893 REMARK 3 5 2.7500 - 2.5500 0.91 2811 154 0.1952 0.2291 REMARK 3 6 2.5500 - 2.4000 0.80 2486 117 0.1935 0.2528 REMARK 3 7 2.4000 - 2.2800 0.72 2205 111 0.1870 0.2165 REMARK 3 8 2.2800 - 2.1800 0.70 2130 109 0.1799 0.2711 REMARK 3 9 2.1800 - 2.1000 0.70 2144 120 0.2001 0.2855 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.252 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.155 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.39 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2973 REMARK 3 ANGLE : 0.859 4034 REMARK 3 CHIRALITY : 0.051 436 REMARK 3 PLANARITY : 0.008 516 REMARK 3 DIHEDRAL : 13.346 400 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8U8J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1000277404. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-AUG-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25654 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.7 REMARK 200 DATA REDUNDANCY : 5.650 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.14700 REMARK 200 FOR THE DATA SET : 6.5300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 70.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.33500 REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 36% PEG 3350, 0.1M TRIS PH 9.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.05000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.98500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.33000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.98500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.05000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.33000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 357 REMARK 465 SER A 358 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 26 CB - CG - CD2 ANGL. DEV. = -10.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 34 38.61 -140.91 REMARK 500 ASP A 147 44.36 -155.61 REMARK 500 ASP A 165 84.12 58.24 REMARK 500 ALA A 187 168.69 68.12 REMARK 500 LEU A 292 50.15 -91.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8U8K RELATED DB: PDB REMARK 900 1ST STRUCTURE (1/2) FROM PAPER REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE RESIDUE NUMBERING IN UNIPROT P28482 IS OFF BY TWO RELATIVE TO REMARK 999 THIS RESIDUE NUMBERING, SUCH THAT ASP-167 IN THE UNIPROT ENTRY IS REMARK 999 ASP-165 IN THIS ENTRY. ALSO, THE CONSTRUCT USED IN THIS STRUCTURE REMARK 999 DETERMINATION LACKS THE MAAAAA AT THE AMINO-TERMINUS, AND HAS THE REMARK 999 FOLLOWING ALANINE SUBSTITUTED BY A SERINE. DBREF 8U8J A 5 358 UNP P28482 MK01_HUMAN 7 360 SEQADV 8U8J SER A 5 UNP P28482 ALA 7 ENGINEERED MUTATION SEQRES 1 A 354 SER GLY ALA GLY PRO GLU MET VAL ARG GLY GLN VAL PHE SEQRES 2 A 354 ASP VAL GLY PRO ARG TYR THR ASN LEU SER TYR ILE GLY SEQRES 3 A 354 GLU GLY ALA TYR GLY MET VAL CYS SER ALA TYR ASP ASN SEQRES 4 A 354 VAL ASN LYS VAL ARG VAL ALA ILE LYS LYS ILE SER PRO SEQRES 5 A 354 PHE GLU HIS GLN THR TYR CYS GLN ARG THR LEU ARG GLU SEQRES 6 A 354 ILE LYS ILE LEU LEU ARG PHE ARG HIS GLU ASN ILE ILE SEQRES 7 A 354 GLY ILE ASN ASP ILE ILE ARG ALA PRO THR ILE GLU GLN SEQRES 8 A 354 MET LYS ASP VAL TYR ILE VAL GLN ASP LEU MET GLU THR SEQRES 9 A 354 ASP LEU TYR LYS LEU LEU LYS THR GLN HIS LEU SER ASN SEQRES 10 A 354 ASP HIS ILE CYS TYR PHE LEU TYR GLN ILE LEU ARG GLY SEQRES 11 A 354 LEU LYS TYR ILE HIS SER ALA ASN VAL LEU HIS ARG ASP SEQRES 12 A 354 LEU LYS PRO SER ASN LEU LEU LEU ASN THR THR CYS ASP SEQRES 13 A 354 LEU LYS ILE CYS ASP PHE GLY LEU ALA ARG VAL ALA ASP SEQRES 14 A 354 PRO ASP HIS ASP HIS THR GLY PHE LEU TPO GLU PTR VAL SEQRES 15 A 354 ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SEQRES 16 A 354 SER LYS GLY TYR THR LYS SER ILE ASP ILE TRP SER VAL SEQRES 17 A 354 GLY CYS ILE LEU ALA GLU MET LEU SER ASN ARG PRO ILE SEQRES 18 A 354 PHE PRO GLY LYS HIS TYR LEU ASP GLN LEU ASN HIS ILE SEQRES 19 A 354 LEU GLY ILE LEU GLY SER PRO SER GLN GLU ASP LEU ASN SEQRES 20 A 354 CYS ILE ILE ASN LEU LYS ALA ARG ASN TYR LEU LEU SER SEQRES 21 A 354 LEU PRO HIS LYS ASN LYS VAL PRO TRP ASN ARG LEU PHE SEQRES 22 A 354 PRO ASN ALA ASP SER LYS ALA LEU ASP LEU LEU ASP LYS SEQRES 23 A 354 MET LEU THR PHE ASN PRO HIS LYS ARG ILE GLU VAL GLU SEQRES 24 A 354 GLN ALA LEU ALA HIS PRO TYR LEU GLU GLN TYR TYR ASP SEQRES 25 A 354 PRO SER ASP GLU PRO ILE ALA GLU ALA PRO PHE LYS PHE SEQRES 26 A 354 ASP MET GLU LEU ASP ASP LEU PRO LYS GLU LYS LEU LYS SEQRES 27 A 354 GLU LEU ILE PHE GLU GLU THR ALA ARG PHE GLN PRO GLY SEQRES 28 A 354 TYR ARG SER MODRES 8U8J TPO A 183 THR MODIFIED RESIDUE MODRES 8U8J PTR A 185 TYR MODIFIED RESIDUE HET TPO A 183 11 HET PTR A 185 16 HET WAL A 401 27 HETNAM TPO PHOSPHOTHREONINE HETNAM PTR O-PHOSPHOTYROSINE HETNAM WAL (4M)-4-{(4R)-3-[(2S)-2-METHYLBUTYL][1,2,4]TRIAZOLO[4,3- HETNAM 2 WAL A]PYRIDIN-7-YL}-N-(1-METHYL-1H-PYRAZOL-5-YL)PYRIMIDIN- HETNAM 3 WAL 2-AMINE HETSYN TPO PHOSPHONOTHREONINE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 1 PTR C9 H12 N O6 P FORMUL 2 WAL C19 H22 N8 FORMUL 3 HOH *231(H2 O) HELIX 1 AA1 HIS A 59 ARG A 75 1 17 HELIX 2 AA2 LEU A 110 GLN A 117 1 8 HELIX 3 AA3 SER A 120 ALA A 141 1 22 HELIX 4 AA4 LYS A 149 SER A 151 5 3 HELIX 5 AA5 THR A 188 ARG A 192 5 5 HELIX 6 AA6 ALA A 193 ASN A 199 1 7 HELIX 7 AA7 LYS A 205 ASN A 222 1 18 HELIX 8 AA8 LEU A 232 GLY A 243 1 12 HELIX 9 AA9 SER A 246 ASN A 251 1 6 HELIX 10 AB1 ASN A 255 SER A 264 1 10 HELIX 11 AB2 PRO A 272 PHE A 277 1 6 HELIX 12 AB3 ASP A 281 LEU A 292 1 12 HELIX 13 AB4 GLU A 301 ALA A 307 1 7 HELIX 14 AB5 HIS A 308 GLU A 312 5 5 HELIX 15 AB6 ASP A 316 GLU A 320 5 5 HELIX 16 AB7 LYS A 328 LEU A 333 5 6 HELIX 17 AB8 PRO A 337 THR A 349 1 13 HELIX 18 AB9 ALA A 350 GLN A 353 5 4 SHEET 1 AA1 2 GLU A 10 VAL A 12 0 SHEET 2 AA1 2 GLN A 15 PHE A 17 -1 O PHE A 17 N GLU A 10 SHEET 1 AA2 5 TYR A 23 GLY A 32 0 SHEET 2 AA2 5 GLY A 35 ASP A 42 -1 O VAL A 37 N GLY A 30 SHEET 3 AA2 5 VAL A 47 ILE A 54 -1 O VAL A 47 N ASP A 42 SHEET 4 AA2 5 VAL A 99 ASP A 104 -1 O GLN A 103 N ALA A 50 SHEET 5 AA2 5 ASP A 86 ILE A 88 -1 N ASP A 86 O VAL A 102 SHEET 1 AA3 3 THR A 108 ASP A 109 0 SHEET 2 AA3 3 LEU A 153 LEU A 155 -1 O LEU A 155 N THR A 108 SHEET 3 AA3 3 LEU A 161 ILE A 163 -1 O LYS A 162 N LEU A 154 SHEET 1 AA4 2 VAL A 143 LEU A 144 0 SHEET 2 AA4 2 ARG A 170 VAL A 171 -1 O ARG A 170 N LEU A 144 LINK C LEU A 182 N TPO A 183 1555 1555 1.33 LINK C TPO A 183 N GLU A 184 1555 1555 1.33 LINK C GLU A 184 N PTR A 185 1555 1555 1.33 LINK C PTR A 185 N VAL A 186 1555 1555 1.33 CISPEP 1 GLY A 20 PRO A 21 0 1.57 CRYST1 42.100 76.660 151.970 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023753 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013045 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006580 0.00000